Fifth industry stakeholder platform on research and development support

This is the fifth in a series of regular meetings between regulators and representatives of industry stakeholder organisations. It addresses all areas of product-development support, from scientific advice and innovation support, as well as specifics for paediatric and orphan medicines.

This meeting focuses on the evolution of the scientific advice framework, the recent launch of IRIS for scientific advice, integrated drug-device combination products (implementation of Art. 117), enhancement of the PRIME scheme, progress with the paediatric action plan and progressing the concept of patient-centred development in practice.